INTRODUCTION
ALMOST six years have elapsed since we reported on the progress in the field ". of tuberculosis of the upper respiratory tract. During this interval considerable progress has been made in the treatment of tuberculosis, particularly since the discovery of streptomycin and paraaminosalicylic acid (PAS). Since the clinical results of the combined use of the two drugs have begun to appear in the international literature, it has become increasingly difficult for us to keep up to date on this particular aspect of otolaryngological tuberculosis. The number of papers published on streptomycin and PAS therapy and on the clinical results and complications are most formidable. At the same time, the major indexing surveys have lagged chronologically behind the countless and dispersed publications.Another drug of therapeutic interest in the treatment of lupus and tuberculous lymphadenopathy proved to be calciferol, which apparently was found to be of great value in